The following research participation opportunity may be of interest. Please see below for more information.
Share Your Thoughts about Ovarian Cancer Treatments
Evidera, a patient-centered research organization, is conducting a 60-minute virtual interview on behalf of a pharmaceutical company, to learn more about patients’ and caregivers’ experience with ovarian cancer treatments and what they would like from a treatment.
They are looking to connect with patients and caregivers (close family members or friends) for a patient who meets the following criteria:
Adults (18 years old or older) who live in the US or UK
Have stage III/IV ovarian cancer, diagnosed within the last 5 years
Have received medicine for ovarian cancer such as chemotherapy or targeted therapy (such as Lynparza, Rubraca, and Zejula)
Those who qualify and complete the virtual interview will be paid $125 USD if you are a US participant and £80 GBP if you are a UK participant. Your participation is voluntary, and information and responses will remain confidential.
Interested?
To see if you qualify for the study or to get more information, please contact contact@global-patients.com.
Treating recurrence with Doxil: Side Effects?
POST SURGERY CHEMOTHERAPY
